EUVIMEDEUVIMED entdecken
LeitlinieOpen Access

ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia

Ignacio Martin-Loeches, Antoni Torres, Blin Nagavci, Stefano Aliberti, Massimo Antonelli, Matteo Bassetti, Lieuwe D Bos, James D Chalmers, Lennie Derde, Jan de Waele, Jose Garnacho-Montero, Marin Kollef und 10 weitere

Intensive Care Medicine · 2023-06 · 49 (6) · 615-632

DOI: 10.1007/s00134-023-07033-8 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Intensive Care Medicine, online erschienen am 04.04.2023. Verfasst von Ignacio Martin-Loeches und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Intensive Care Medicine, Multidisciplinary Intensive Care Research Organisation (MICRO), St James's Hospital, Dublin, Ireland. drmartin…. Hauptthemen laut MEDLINE: Pneumonia, Communicable Diseases. Die Arbeit wurde bisher 306-mal zitiert (Crossref) und nennt 115 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Severe community-acquired pneumonia (sCAP) is associated with high morbidity and mortality, and whilst European and non-European guidelines are available for community-acquired pneumonia, there are no specific guidelines for sCAP. METHODS: The European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), and Latin American Thoracic Association (ALAT) launched a task force to develop the first international guidelines for sCAP. The panel comprised a total of 18 European and four non-European experts, as well as two methodologists. Eight clinical questions for sCAP diagnosis and treatment were chosen to be addressed. Systematic literature searches were performed in several databases. Meta-analyses were performed for evidence synthesis, whenever possible. The quality of evidence was assessed with GRADE (Grading of Recommendations, Assessment, Development and Evaluation). Evidence to Decision frameworks were used to decide on the direction and strength of recommendations. RESULTS: Recommendations issued were related to diagnosis, antibiotics, organ support, biomarkers and co-adjuvant therapy. After considering the confidence in effect estimates, the importance of outcomes studied, desirable and undesirable consequences of treatment, cost, feasibility, acceptability of the intervention and implications to health equity, recommendations were made for or against specific treatment interventions. CONCLUSIONS: In these international guidelines, ERS, ESICM, ESCMID, and ALAT provide evidence-based clinical practice recommendations for diagnosis, empirical treatment, and antibiotic therapy for sCAP, following the GRADE approach. Furthermore, current knowledge gaps have been highlighted and recommendations for future research have been made.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PneumoniaCommunicable DiseasesHumansCritical Care

Autor:innen und Institutionen

  • Department of Intensive Care Medicine, Multidisciplinary Intensive Care Research Organisation (MICRO), St James's Hospital, Dublin, Ireland. drmartinloeches@gmail.com.
  • Trinity College Dublin, Dublin, Ireland. drmartinloeches@gmail.com.
  • CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, Madrid, Spain. drmartinloeches@gmail.com.
  • Pulmonary Department, Hospital Clinic, Universitat de Barcelona, IDIBAPS, ICREA, Barcelona, Spain. drmartinloeches@gmail.com.
  • CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, Madrid, Spain.
  • Pulmonary Department, Hospital Clinic, Universitat de Barcelona, IDIBAPS, ICREA, Barcelona, Spain.

Zitieren

APA

Martin-Loeches, I., Torres, A., Nagavci, B., Aliberti, S., Antonelli, M., Bassetti, M., Bos, L. D., Chalmers, J. D., Derde, L., de Waele, J., Garnacho-Montero, J., Kollef, M., Luna, C. M., Menendez, R., Niederman, M. S., Ponomarev, D., Restrepo, M. I., Rigau, D., Schultz, M. J., …, & Wunderink, R. (2023). ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia. Intensive Care Medicine, 49(6), 615-632. https://doi.org/10.1007/s00134-023-07033-8

Vancouver

Martin-Loeches I, Torres A, Nagavci B, Aliberti S, Antonelli M, Bassetti M, et al. ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia. Intensive Care Medicine. 2023;49(6):615-632. doi:10.1007/s00134-023-07033-8

BibTeX
@article{MartinLoeches2023,
  author = {Martin-Loeches, Ignacio and Torres, Antoni and Nagavci, Blin and Aliberti, Stefano and Antonelli, Massimo and Bassetti, Matteo and Bos, Lieuwe D and Chalmers, James D and Derde, Lennie and de Waele, Jan and Garnacho-Montero, Jose and Kollef, Marin and Luna, Carlos M and Menendez, Rosario and Niederman, Michael S and Ponomarev, Dmitry and Restrepo, Marcos I and Rigau, David and Schultz, Marcus J and Weiss, Emmanuel and Welte, Tobias and Wunderink, Richard},
  title = {ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia},
  journal = {Intensive Care Medicine},
  year = {2023},
  volume = {49},
  number = {6},
  pages = {615--632},
  doi = {10.1007/s00134-023-07033-8}
}
Kostenlos starten →